Diabetes‐induced upregulation of kallistatin levels exacerbates diabetic nephropathy via RAS activation

Kallistatin is an inhibitor of tissue kallikrein and also inhibits the Wnt pathway. Its role in diabetic nephropathy (DN) is uncertain. Here we reported that serum kallistatin levels were significantly increased in diabetic patients with DN compared to those in diabetic patients without DN and healt...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yanhui, He, Xuemin, Cheng, Rui, Chen, Qian, Shan, Chunyan, Chen, Liming, Ma, Jian‐xing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302980/
https://www.ncbi.nlm.nih.gov/pubmed/32352602
http://dx.doi.org/10.1096/fj.201903149R

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302980/
https://www.ncbi.nlm.nih.gov/pubmed/32352602
http://dx.doi.org/10.1096/fj.201903149R

Ejemplares similares